Pulmonary hypertension is a rare disease that affects lung arteries causing their progressive narrowing. Diagnosis generally occurs late, when treatment options are less, because there are not any diagnostic tools for early detection. On the occasion of the World Pulmonary Hypertension Day on May 5th, the Fundación Contra la Hipertensión Pulmonar (FCHP), a foundation against pulmonary hypertension, has launched a crowd funding platform to sponsor a research project called Enpathy; its main objectives are to facilitate early diagnoses and to find a definitive cure. The project involves scientists from several Spanish hospitals and universities, the Universidad de Valladolid, for instance.